PAIN
Volume 141, Issue 1 , Pages 14-18, January 2009

Comparison of chronic analgesic drugs prevalence in Parkinson’s disease, other chronic diseases and the general population

  • Christine Brefel-Courbon

      Affiliations

    • Service de Pharmacologie Clinique, CHU Toulouse, France
    • INSERM, U825, Toulouse, France
    • Université Toulouse III Paul Sabatier, Toulouse, France
    • Corresponding Author InformationCorresponding author. Address: Department of Pharmacology, Faculty of Medicine, 37 allées jules Guesde, 31000 Toulouse, France. Tel.: +33 5 61 14 59 62; fax: +33 5 61 25 51 16.
  • ,
  • Sabrina Grolleau

      Affiliations

    • EA 3696, Toulouse, Université Toulouse III Paul Sabatier, France
  • ,
  • Claire Thalamas

      Affiliations

    • INSERM, Centre d’Investigation Clinique 9302, Toulouse, France
  • ,
  • Robert Bourrel

      Affiliations

    • CNAMTS – Service médical Midi-Pyrénées, France
  • ,
  • Valérie Allaria-Lapierre

      Affiliations

    • CNAMTS – Service médical Provence-Alpes-Côte d’Azur-Corse, France
  • ,
  • Robert Loï

      Affiliations

    • CNAMTS – Service médical Provence-Alpes-Côte d’Azur-Corse, France
  • ,
  • Joelle Micallef-Roll

      Affiliations

    • Fédération de pharmacologie et de toxicologie, CHU Timone, Marseille, France
  • ,
  • Maryse Lapeyre-Mestre

      Affiliations

    • Service de Pharmacologie Clinique, CHU Toulouse, France
    • EA 3696, Toulouse, Université Toulouse III Paul Sabatier, France

Received 6 November 2007; received in revised form 7 April 2008; accepted 25 April 2008. published online 08 December 2008.

Abstract 

Patients with Parkinson’s disease (PD) frequently experienced pain. Nevertheless, there are no epidemiological data about frequency of pain in PD. We compare pain prevalence using analgesic prescription in PD patients, in the general population and in two samples of painful patients: diabetics and osteoarthritis patients in France. Data were obtained from the French System of Health Insurance for the year 2005. Medications (antiparkinsonian, antidiabetics drugs and osteoarthritis drugs) were used for identification of PD, diabetic and osteoarthritis patients. We estimated the prevalence of analgesic drugs prescription (at least one analgesic drug) and the prevalence of chronic analgesic drugs prescription (more than 90 DDD of analgesic drug). The study included 11,466 PD patients. PD patients significantly received more prescription of analgesics than the general population (82% versus 77%,) and fewer than patients with osteoarthritis (82% versus 90%). No significant difference was found between PD and diabetic patients. The chronic prescription of analgesic drugs was more prevalent in PD patients (33%) than in the general population (20%) and in diabetic patients (26%) and similar to that in osteoarthritis patients. PD patients were more exposed than the general population and diabetics to opiates, acetaminophen, and adjuvant analgesics chronic use.

Keywords: Parkinson’s disease, Chronic pain, Prevalence, Analgesic drugs

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3959(08)00234-0

doi:10.1016/j.pain.2008.04.026

PAIN
Volume 141, Issue 1 , Pages 14-18, January 2009